https://www.selleckchem.com/products/nsc16168.html
Despite increases in treatment uptake for hepatitis C viral infection (HCV) in Australia since the introduction of direct acting antiviral (DAA) therapy, a large proportion of HCV-infected people who inject drugs (PWID) have not sought treatment. To examine predictors of treatment uptake and reasons for not seeking treatment among PWID. PWID ( = 404) recruited through five needle and syringe programs in South East Queensland were interviewed about HCV testing, status and treatment, recent injecting drug use, mental health and reasons
Like
Comment
Share
